JNJ

Johnson & Johnson (JNJ)

Last Price$159.61.1%
Market Cap$383.4B
LTM Return on Equity (ROE)
19.9%
5Y avg
23.4%
Drug Manufacturers - General industry median
19.9%
Stock quality & Intrinsic value
6/10
0.2% undervalued

Johnson & Johnson Return on Equity (ROE)

Annual
Quarterly
LTM
Industry median
Company stand-alone
JNJ
Healthcare
Crunching data... Almost there!
Jan'05Jan'06Dec'06Dec'07Dec'08Jan'10Jan'11Jan'12Dec'12Dec'13Dec'14Jan'16Jan'17Dec'17Dec'18Dec'19Jan'21Jan'22Jan'23Dec'23
Return on Equity (ROE)
26.7%
29.9%
28.6%
25.6%
30.2%
26.4%
24.9%
17.0%
17.2%
19.9%
22.8%
22.0%
23.4%
2.0%
25.5%
25.4%
24.0%
30.4%
23.8%
18.3%
JNJ
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for JNJ and see if it's the right time to invest.
Dive in

Johnson & Johnson (JNJ) Return on Equity (ROE) comparison analysis

Crunching data... Almost there!

JNJ key stats

USD
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Johnson & Johnson's Return on Equity (ROE)?

As of today, Microsoft Corp's last 12-month Return on Equity (ROE) is 19.9%, based on the financial report for Dec 29, 2024 (Q4 2024). The average annual Return on Equity (ROE) for Johnson & Johnson have been 22.7% over the past three years, and 24.6% over the past five years.

2) Is Johnson & Johnson's Return on Equity (ROE) Good?

As of today, Johnson & Johnson's Return on Equity (ROE) is 19.9%, which is lower than industry median of 19.9%. It indicates that Johnson & Johnson's Return on Equity (ROE) is Bad.

3) How does Johnson & Johnson's Return on Equity (ROE) compare to its peers?

As of today, Johnson & Johnson's Return on Equity (ROE) is 19.9%, which is lower than peer median of 23.7%. The list of peers includes ABBV, LLY, AMGN, MRK, NVS, AZN, PFE, SNY, GILD, BMY.